This inventor holds 1 USPTO granted patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Toshihiro Hirai: Innovator in Hepatic Metastases Research
Introduction
Toshihiro Hirai is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His innovative work focuses on developing suppressory compositions against hepatic metastases of tumors.
Latest Patents
Hirai holds a patent for his invention titled "Suppressory compositions against hepatic metastases of tumors." This patent describes compositions that include a phosphoric acid diester compound, which can be used to combat tumor metastases in the liver. The patent highlights the potential of these compositions to improve treatment outcomes for patients suffering from liver metastases.
Career Highlights
Throughout his career, Toshihiro Hirai has been associated with Senju Pharmaceutical Co., Ltd., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of tumor metastasis and developing effective therapeutic strategies.
Collaborations
Hirai has collaborated with esteemed colleagues such as Tetsuya Toge and Kenichi Yoshida. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.
Conclusion
Toshihiro Hirai's contributions to the field of cancer research, particularly through his patent on suppressory compositions against hepatic metastases, underscore his role as a significant innovator. His work continues to inspire advancements in medical treatments for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile